Emedastine Difumarate Patent Expiration
Emedastine Difumarate is Used for treating allergic conjunctivitis. It was first introduced by Novartis Pharmaceuticals Corp
Emedastine Difumarate Patents
Given below is the list of patents protecting Emedastine Difumarate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Emadine | US5441958 | Ophthalmic compositions comprising emedastine and methods for their use |
Dec 08, 2013
(Expired) | Novartis |